IFCCPRESIDENT ELECT

NOMINATIONS

2020 - 2023

LIST OF CANDIDATES

Nominees

Khosrow Adeli

Päivi Laitinen

Tomáš Zima

National Society

Canadian Society of Clinical Chemists (CSCC)

Finnish Society of Clinical Chemistry (SKKY)

Czech Society of Clinical Biochemistry (CSKB)

Khosrow ADELI

CANADIAN SOCIETY OF CLINICAL CHEMISTS (CSCC)

1

NOMINATION FORM for PRESIDENT

IFCC EXECUTIVE BOARD 2021-2023

To be sent via e-mail to the IFCC Office at ifcc@ifcc.org 1. Nomination by National Society On behalf of …Canadian Society of Clinical Chemists…………. (insert name of National Society) Name: Stephen Hill………………………………………… Office held within the National Society:….President……………..

(This should normally be the nominated National Representative to the IFCC Council)

We nominate for the Office of President for the term 2021-2023 (to begin as President-elect in 2020): Dr. Khosrow Adeli………………………………....

(insert name of nominee)

Signature:…… ..

Date: …2019-02-11…………….. 2. Acceptance by Nominee I, ………Khosrow Adeli…………………… Date of Birth: …March 21, 1953…….. (insert name)

accept nomination for election to the position of President

and accept the obligations and time commitment required for this position, if elected.

My contact details are:

Address: Clinical Biochemistry, Paediatric Laboratory Medicine The Hospital for Sick Children, University of Toronto Phone: …416-813-8682…

Fax: …416-813-6257…

Email: …k.adeli@utoronto.ca…

Signature: … Date: …March 5, 2019……….

2

3. Details supplied by nominee

Please supply information for circulation to the National Societies. This should include details of previous service within IFCC, national or regional organisations; professional position(s) currently held and major professional, scientific or clinical interests; and a position statement outlining issues which you see as important for the IFCC and how you might address them. A full curriculum vitae is not required. As a guide, one page of single-spaced text should be sufficient. Khosrow Adeli PhD, FCACB, DABCC, FAACC

Professor Adeli is currently the Head of Clinical Biochemistry at the Hospital for Sick Children and the Vice-Chair of Laboratory Medicine & Pathology at the University of Toronto in Toronto, Canada. He is also a senior scientist in Molecular Medicine at the Research Institute, The Hospital for Sick Children. He is very well known for his extensive national and international contributions over the past 30 years to clinical laboratory service, research, and education. He has also held several leadership positions nationally and internationally including:

*Chair, IFCC Communications and Publications Division (2013-2018) *Chair, IFCC Public Relations Committee (2007-2012) *Board of Directors, American Association of Clinical Chemistry (AACC) Academy (2015-2018) *Editor-in-Chief, Critical Reviews in Clinical Laboratory Sciences (2013-present) (Impact Factor: 6.4) *Chair, Diabetes Grant Review Committee, Canadian Institutes of Health Research (CIHR) (2016-2019) *Scientific Advisory Board, International Centre in Genetic Engineering and Biotechnology (2009-2018) *President, The Commission on Accreditation in Clinical Chemistry (COMACC) (2007-2010) *Editor-in-Chief, Clinical Biochemistry (1999-2006) *Chair, Canadian Academy of Clinical Biochemistry (1999-2001)

The impact of Professor Adeli’s contributions to the field of clinical chemistry and laboratory medicine have been profound and recognized through several national and international awards including:

*2019 AACC Outstanding Research Award in Clinical Chemistry, American Association of Clinical Chemistry *2018 Hungarian Academy Honorary Award, Hungarian Academy of Laboratory Medicine *2016 CSCC Innovation Award in Laboratory Medicine, Canadian Society of Clinical Chemists *2015 AACC Pediatric-Maternal-Fetal Division Award, American Association of Clinical Chemistry *2015 OSCC Lifetime Achievement Award, Ontario Society of Clinical Chemists *2015 CSCC Outstanding Education Award, Canadian Society of Clinical Chemists *2014 Distinguished Service Award in Laboratory Medicine, University of Toronto *2014 CSATVB Scientific Excellence Award, Canadian Society of Atherosclerosis, Thrombosis, & Vascular Biology *2010 COMACC Service Award, The Commission on Accreditation in Clinical Chemistry *2006 CSCC Outstanding Contributions to Clinical Chemistry, Canadian Society of Clinical Chemists *2004 CACB Outstanding Contributions to Clinical Biochemistry, Canadian Academy of Clinical Biochemistry

(several other awards not listed)

Contributions to IFCC and its Membership: Professor Adeli recently completed a 12-year term on the IFCC Communications and Publications Division (CPD). He initially served as Vice-Chair and later as Chair over the past 6 years. CPD is responsible for all IFCC publications and communication activities including the eNews, eJournal, website, eAcademy/eLearning, and public relations activities. During his term as Chair, he worked closely with the CPD executive, committees, and working groups and played a leadership role in significantly enhancing publication and communication activities of the IFCC organization. Key achievements of CPD over the past 10 years include:

*Creation of a new and much improved IFCC website (better design, functionality, user-friendliness, content) *Publication of a much improved IFCC newsletter, growing from 4 issues a year, to now almost monthly

publications (11 issues published in 2018) with contributions from clinical chemistry societies around the world *Creation of a Public Relations (PR) Committee and a global PR campaign on value of lab medicine in healthcare *Successful indexing of the IFCC Electronic Journal (eJIFCC) in PubMed and significantly improved content in terms

of both quality of published work and quantity of articles published annually *Development of an IFCC Mobile App to facilitate ready access to IFCC media *Development of a new eLearning program (the “IFCC eAcademy”) to provide educational webinars worldwide *Expansion of a Spanish language communication initiative across Latin America (RIA [Rincón Iberoamericano] and

DIV [Diagnóstico in Vitro] Magazine)

3

Professor Adeli has also directly interacted with and personally knows IFCC national representatives from dozens of countries around the world as well as corporate members. As a result of his IFCC contributions and research achievements, he has been invited to deliver numerous presentations to IFCC national societies and/or regional/international conferences in many countries including: Argentina, Australia, Brazil, China, Ecuador, France, Germany, Greece, Hungary, India, Indonesia, Iran, Italy, Korea, Mexico, Morocco, Netherlands, Paraguay, Philippines, Poland, Qatar, Russia, South Africa, Spain, Turkey, UAE and Uruguay. He has therefore developed strong relationships with many IFCC member societies as well as many IFCC officers within the IFCC organization.

Contributions to Research in Laboratory Medicine: In addition to his IFCC contributions, the basic and translational research in Professor Adeli’s laboratory have been extremely productive and yielded a career total of 290 peer-reviewed full articles as well as hundreds of abstracts/conference presentations. The scientific impact of his work has been extensive, as evidenced by numerous citations to his publications (Google Scholar Statistics: h-index of 68 and i10-index of 232, with over 21,000 citations). Furthermore, he has personally delivered a total of 56 invited presentations since 2010 at national and international conferences or universities/research centers worldwide. One of his most significant contributions to the field of clinical chemistry has been in the area of reference intervals, leading to the development of the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) (www.caliperproject.org). His original CALIPER studies have closed the evidence gaps in pediatric reference intervals with major global impact. Hundreds of clinical laboratories in the US, Canada, and in over 100 countries around the world currently use CALIPER pediatric reference intervals in their routine clinical practice.

Contributions to Education in Laboratory Medicine: In the area of education, Professor Adeli has been the Director of the Postdoctoral Training Program at the University of Toronto for over 20 years. He has directly mentored more than 50 clinical chemistry fellows, many of whom now hold prominent positions in laboratories across Canada, the US, and other countries. He also served (2006-2010) as the President of COMACC, the Commission on Accreditation in Clinical Chemistry, (a North American organization responsible for accreditation of clinical chemistry training programs in the US and Canada). In further recognition of his national and international contributions to education, Professor Adeli received the 2010 COMACC Leadership Award and the 2012 CSCC Education Award.

Personal Statement and Vision: I strongly feel that I can be very effective in this leadership position in light of my considerable experience with the IFCC organization, my numerous links to IFCC membership and member countries, as well as my productive track record during my term as IFCC division chair. I have over 30 years of experience in several senior leadership positions in the field of laboratory medicine within my own institution, my national clinical chemistry community, as well as internationally within IFCC and AACC. My accomplishments in all areas of clinical chemistry service, research, education, as well as outreach and communication, have prepared me well for such a position and would allow me to make important contributions to the IFCC’s mission of “advancing excellence in laboratory medicine for better healthcare worldwide”. I have the background and experience to drive further advancements in key areas of the IFCC’s mission including scientific leadership in the field of lab medicine, global educational activities, and innovative communication strategies within and outside the field of lab medicine at an international level. I strongly believe that the IFCC organization is in a unique leadership position to:

1) Continue to promote the value of laboratory medicine by gathering the evidence to demonstrate the value of lab medicine in clinical decision making and healthcare delivery, communicating this to the public and all stakeholders.

2) Become the leader in developing practice guidelines to ensure optimal application and utilization of diagnostic services and improved clinical decision making using IFCC’s extensive and wide-ranging scientific expertise.

3) Develop innovative quality improvement strategies and disseminate the concept of total quality management and quality systems approach to clinical laboratories and national societies, particularly in developing countries.

4) Become the largest provider of free Distance Learning/eLearning in the field of laboratory medicine worldwide. Through the new eAcademy platform and its vast network of experts, IFCC can develop the most comprehensive database of eLearning programs to support education by its member societies particularly in developing countries.

5) Encourage and support a culture of innovation in the IFCC community and communicate technological and process innovations to laboratory scientists and physicians globally. In association with regional federations, member societies, young scientists and corporate members, ensure that IFCC is a driver of technological innovations such as artificial intelligence and machine learning, and their application in laboratory medicine.

The future holds considerable promise for the IFCC organization and its family of national societies and corporate members. I look forward to being part of the IFCC’s continued journey towards global leadership in lab medicine, contributing to its most valuable mission of improving clinical decision making and better healthcare worldwide.

OFFICERS 2018 – 2019

PRESIDENT

Stephen Hill

PRESIDENT-ELECT Edward Dunn

SECRETARY

Jennifer Shea

TREASURER Ivan Blasutig

COUNCILLORS

Anna Fuezery Danijela Konforte Nicolas Tétreault

DIVISION HEADS Education & Scientific

Affairs Allison Venner

Professional Affairs Julie Shaw

Publications Isolde Seiden-Long

EXECUTIVE DIRECTOR Pamela Lyons

CSCC 2019 63rd Annual Meeting

June 2-5, 2019 Saint John NB

Head Office 4 Cataraqui Street

Suite 310 Kingston ON K7K 1Z7

Tel 613.531.8899 Fax 613.531.0626 office@cscc.ca www.cscc.ca

2019-03-25 Dr. Graham Beastall, Chair IFCC Nominations Committee IFCC@IFCC.org Dear Dr. Beastall,

Re: Dr. Khosrow Adeli

It is my pleasure, on behalf of the Canadian Society of Clinical Chemists, to nominate Dr. Khosrow Adeli as President of the IFCC. Dr. Adeli is the Head of Clinical Biochemistry at the Hospital for Sick Children and Professor of Pathology and Laboratory Medicine at the University of Toronto. He has served the Federation in several leadership positions. I am certain that he would serve the Federation well as President. The required documents are attached. Please contact me if further information is required. Sincerely

Stephen Hill PhD, FCACB President, Canadian Society of Clinical Chemists Copies P. Lyons, Executive Director Jennifer Shea, Secretary Ted Dunn, President Elect

Päivi LAITINEN

FINNISH SOCIETY OF CLINICAL CHEMISTRY (SKKY)

1

NOMINATION FORM for PRESIDENT

IFCC EXECUTIVE BOARD 2021-2023

To be sent via e-mail to the IFCC Office at ifcc@ifcc.org 1. Nomination by National Society On behalf of ……Finnish Society of Clinical Chemistry. (insert name of National Society) Name:……Anna Linko-Parvinen…………………………………… Office held within the National Society: ………President…..

(This should normally be the nominated National Representative to the IFCC Council)

We nominate for the Office of President for the term 2021-2023 (to begin as President-elect in 2020): Päivi Laitinen ……………………………………………………………………………………………....

(insert name of nominee) Signature:…………………………………………………………………………………..

Date: ……April 10, 2019……………………………….. 2. Acceptance by Nominee Päivi Laitinen………………………………………………… Date of Birth: ……July 28, 1955 (insert name) accept nomination for election to the position of President and accept the obligations and time commitment required for this position, if elected. My contact details are: Address: … HUSLAB……………………………………………………………………….. ………………… PO Box 720, Topeliuksenkatu 32, 00029 HUS…………………………… ………………… Finland… ………………………………………………………… Phone: …………+358 505499 622………….. Fax: …………………….. Email: …………paivi.h.laitinen@hus.fi………..

Signature:… …… Date: ………April 9, 2019……………

2

3. Details supplied by nominee Please supply information for circulation to the National Societies. This should include details of previous service within IFCC, national or regional organisations; professional position(s) currently held and major professional, scientific or clinical interests; and a position statement outlining issues which you see as important for the IFCC and how you might address them. A full curriculum vitae is not required. As a guide, one page of single-spaced text should be sufficient. Päivi Laitinen is Chief Chemist in HUSLAB, Laboratory of Helsinki University Hospital and in that role she is responsible of the technical and analytical issues as well as acquisitions of Clinical Chemistry and Pre-analytical Services of HUSLAB. Päivi Laitinen obtained her PhD in Biochemistry and Master’s degree in Health Care Administration at Oulu University. Her scientific interests focus presently mainly on the use and implementation of cardiac markers. At the moment she chairs an EFLM Task Group Cardiac Markers. She has published about 50 peer-reviewed articles. Päivi Laitinen has been actively involved in the activities of the scientific societies of clinical chemistry and laboratory medicine at the international, European and national level. Päivi Laitinen served as Secretary of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Executive Board in 2006-2011. She has also been a member of the IFCC Awards Committee (2003-2005), Chair and Past Chair of Nominations Committee (2012-2017). The international activities include memberships of the European Communities Confederation of Clinical Chemistry (EC4) Board (2003-2005) and Scandinavian Society of Clinical Chemistry Board (1998-2002). Päivi Laitinen has been an active member of the Finnish Society of Clinical Chemistry since 1987 and served as President of the Society in1998-2002. She has been a member of the Finnish Clinical Chemistry Register Committee (EC4) 1998-2002, and a member of the Working Group on Laboratory Nomenclature of the Finnish Union of Counties 1999-2013. Position statement: Clinical laboratories have faced enormous changes during the past decades. We have experienced the transfer from manual methods of small local laboratories to huge total automation laboratories which handle thousands of sample tubes a day. At the same time the quality of methods has improved dramatically, mainly due to the standardization efforts of IFCC and IVD industry. Accreditation of clinical laboratories has improved the documentation and processes of laboratories. The emphasis has been on the quality of laboratory services as well as handling of the growing volume of services. I think IFCC must look into the future showing the real value of laboratory services and take the global leadership in this role. This can be achieved by collaboration with clinical associations as well as with IVD industry in all levels, local, national, regional and international. This is a joint effort. IFCC is the leading scientific organization in the field of laboratory medicine. In this role IFCC should focus on the following:

1. The high quality of laboratory services is essential for the whole healthcare and impacts patient safety. The main focus of IFCC has been in the standardization and harmonization as well as traceability of laboratory tests, which are the key components of high quality laboratory services. I believe this remains to be backbone of IFCC activities. Laboratories also need to improve their processes in order to meet the increasing demands of patient care. This means that we need to do more, we need to do it faster with less budget. We need tools for following the key performance indicators of processes and for this data mining we need laboratory information systems. I think IFCC should take a leading role in advancing these activities.

2. Clinical laboratories have been considered to be merely service providers and not equal partners in healthcare. IFCC has taken steps into showing evidence of the value of laboratory medicine as part of healthcare and we need to continue this effort in collaboration with clinical associations and patient organizations. We make difference! I believe IFCC can take a key role in this collaboration.

3. Patient care is guided by international and national guidelines. These guidelines are often written without participation of laboratory professionals. There is evidence that these guidelines are not always followed by laboratories. I think IFCC should seek collaboration with clinical associations in writing these guidelines in a way that the methods used and laboratory processes are considered.

4. IFCC has now 92 Full Members. IFCC should seek new members (Full and Affiliate), especially among emerging nations and other societies of laboratory medicine. I believe new companies, like IT companies should be considered as Corporate Members.

3

5. Today environment is a concern of all people. Laboratory activities have impact on environment due the use of electricity, water and production of waste etc. Laboratories can do a lot to reduce, reuse and recycle. I think IFCC should take a leadership role in guiding laboratories for sustainability. IFCC should also seek ways of considering environment when planning its meetings, congresses and conferences.

As President of IFCC I shall focus on the activities on improving the quality of laboratory services

and collaboration between IFCC and clinical associations and patient organizations. The next Executive Board needs to focus on the sustainability of IFCC activities and laboratories. I shall also strengthen the collaboration between IFCC officials in Divisions, Committees, Working Groups and Task Forces as well as national societies and corporate members.

Päivi Laitinen Chief clinical chemist/ PhD, Adjunct Professor, EuSpLM

10th April 2019 Turku, Finland

To whom it may concern,

Please find enclosed our nomination for the IFCC President/IFCC Executive Board (EB) for the term 2021-2023. We kindly propose chief chemist, adj. prof. Päivi Laitinen for the position. Her primary scientific interests are with the use and implementation of cardiac markers and she has circa 50 peer-reviewed scientific papers. Päivi Laitinen has been an active and enthusiastic member in the national and international societies, including IFCC, where she has served in several positions. She has wide international connections, and she is eager to develop the work of the IFCC. The application form describes her work and position statement in detail. Dr. Päivi Laitinen is fully eligible for the position. The board of the Finnish Society of Clinical Chemistry fully supports Päivi Laitinen for the position of the IFCC president. On behalf oh the Finnish Society of Clinical Chemistry,

Anna Linko-Parvinen MD, Ph.D. President of Finnish Society of Clinical Chemistry Turku University Hospital Laboratory of Hematology Turku, Finland tel. +358405598212 e-mail. anna.linko-parvinen@tyks.fi

Tomáš ZIMA

CZECH SOCIETY OF CLINICAL BIOCHEMISTRY (CSKB)

Czech Medical Association J. E. Purkyne

CZECH SOCIETY OF CLINICAL BIOCHEMISTRY ww

w.c

skb.

cz

sekr

etar

iat@

cskb

.cz

NOMINATION COVER LETTER

10th April 2019 To: Dr. Graham H Beastell Chair IFCC Nominations Committee ifcc@ifcc.org; gbeastall@googlemail.com Dear Dr. Beastell, I am delighted, on behalf of the Czech Society of Clinical Biochemistry, to nominate Professor Tomáš Zima, M.D., DSc. MBA as President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The Czech Society of Clinical Biochemistry (CSKB) unanimously recommended his nomination at the last CSKB Committee meeting. Tomáš Zima has served the Czech Society of Clinical Biochemistry, the IFCC Committee and the European Federation of Clinical Chemistry and Laboratory Medical for several years. We greatly appreciate his diligence, leadership, organizational and communication skills and especially his advocacy for clinical biochemistry both in the Czech Republic and throughout Europe. I am convinced that Tomáš Zima will contribute significantly to the further development of the International Federation of Clinical Chemistry and Laboratory Medicine. Yours sincerely

Richard Pikner, M.D., Ph.D. Vice-president CSKB IFCC and EFLM representative Copies: Jaroslav Racek, CSKB President Tomáš Zima, Nominee

President: Prof. Jaroslav Racek, MD, DSc. Inst. Clin. Biochem. Hematol. Charles University Hospital Alej Svobody 80 CZ-304 60 Pilsen phone: +420 377 104 233 e-mail: racek@fnplzen.cz Vice-President, IFCC Representative Richard Pikner, MD, PhD Department of Clinical Laboratories and Bone Metabolism Klatovy Hospital Plzeňská 929 CZ-339 01 Klatovy phone: +420 376 335 875 e-mail: richard.pikner@klatovy.nemocnicepk.cz Vice-President: Assoc. Prof. Drahomíra Springer, PhD Inst. of Medical Biochemistry Lab. Med. First Faculty of Medicine Charles University and General University Hosp. U Nemocnice 2 CZ-128 08 Prague 2 phone: +420 224 962 883 fax: +420 224 962 848 e-mail: springer@vfn.cz Secretary: Pavel Malina, MD, PhD Department of Clinical Biochemistry Písek Hospital Karla Čapka 589 CZ-397 01 Písek phone: +420 382 772 120 e-mail: malina@nemopisek.cz Treasurer: Petr Kubáč, MD Department of Clinical Biochemistry City Hospital Ostrava Nemocniční 20 CZ-728 80 Ostrava phone: +420 725 500 657 e-mail: petr.kubac@mnof.cz Member-at-Large: Prof. Tomáš Zima, MD, DSc. Inst. of Medical Biochemistry Lab. Med. First Faculty of Medicine Charles University and General University Hosp. U Nemocnice 2 CZ-128 08 Prague 2 phone: +420 224 962 841 fax: +420 224 962 848 e-mail: zimatom@cesnet.cz Member-at-Large: Dagmar Gotzmannová, PhD Spadia Lab Dr. Martínka 1491/7 CZ-700 30 Ostrava-Hrabůvka phone: +420 724969324 e-mail: dagmar.gotzmannova@gmail.com Section of Laboratory Technicians -charmain: Mgr. Martina Bunešová Dept. Of Med, Chem & Clin. Biochem. University Hospital Motol V Úvalu 84 CZ-150 06 Prague 5 Phone : +420 224 435 318 Fax : +420 224 435 320 E-mail : bunesovam,@seznam.cz Technical Secretariat: Miroslava Beranová Inst. of Medical Biochemistry Lab. Med. First Faculty of Medicine Charles University and General University Hosp. U Nemocnice 2 CZ-128 08 Prague 2 phone: +420 224 962 841 fax: +420 224 962 848 e-mail: sekretariat@cskb.cz